Details for New Drug Application (NDA): 019863
✉ Email this page to a colleague
The generic ingredient in GEREF is sermorelin acetate. There is one drug master file entry for this compound. Additional details are available on the sermorelin acetate profile page.
Summary for 019863
Tradename: | GEREF |
Applicant: | Emd Serono |
Ingredient: | sermorelin acetate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 28, 1990 | TE: | RLD: | Yes |
Expired US Patents for NDA 019863
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Emd Serono | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 019863-001 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Emd Serono | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 019863-001 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription